By Buy This GLP Editorial Team · Editorial profile: Neil Sanders
Raeliva review
Four formulation prices
Raeliva lists compounded injections and dissolving tablets. Lower monthly equivalents require upfront payment.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
Raeliva lists monthly injection plans at $219 for compounded semaglutide and $299 for tirzepatide. Its monthly dissolving tablet rates are $260 and $359, respectively.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Pricing transparency
How Raeliva publishes its prices
The three-month injection plan is billed as $500 upfront for semaglutide. Somira Health’s three-month semaglutide price offers another upfront total to compare over the same term. Its six-month semaglutide injection plan costs $900 upfront. The lower monthly equivalent depends on that longer commitment.
At a glance
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What Raeliva is
Raeliva coordinates online treatment with independent providers. It lists both compounded drugs as injections and oral dissolving tablets.
How it works
Its FAQ says the plan price includes provider review, medication if prescribed, shipping and ongoing support.
Branded or compounded
These are compounded products. The FDA does not approve the formulations listed here.
Where the money holds, and where it moves
Predictable
- Lists injection and tablet prices separately
- Publishes the amount due for semaglutide terms
Moves, or is not stated
- Lower monthly equivalents require prepayment
- The compounded tablets are not FDA-approved
Who this is worth it for
People comparing month-to-month injection and tablet offers.
Who should price elsewhere
People who want an FDA-approved branded oral formulation.
The molecules
What Raeliva prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside Raeliva
- HealthRX
Buyers who want to see the published monthly renewal before starting intake
See HealthRX →
LibertyPeople who can confirm their selected plan’s actual price.
See Liberty →
Ozari HealthPeople comparing the full price and eligibility of monthly and quarterly offers.
See Ozari Health →
More GLP-1 telehealth sellers priced end to end: Hormonally BalancedJM Integrated HealthKairoRxKIN HealthKlarity HealthKlinic
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Frequently asked
Are the injection rates different from the tablet rates?
How do longer plans bill?
Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare Raeliva against every seller on it.